The GOSR2 Gene Progressive Myoclonus Epilepsy Type 6 Genetic Test is a specialized diagnostic tool used to identify mutations in the GOSR2 gene, which are associated with Progressive Myoclonus Epilepsy Type 6 (PME6). This condition is a rare genetic disorder characterized by myoclonic seizures, ataxia, and progressive neurological decline. Early and accurate diagnosis through genetic testing can help in managing symptoms, tailoring treatment plans, and providing genetic counseling for affected individuals and their families.
The test involves collecting a DNA sample, typically through a blood draw, and analyzing the GOSR2 gene for specific mutations. It is a crucial step for families with a history of PME6, providing them with valuable information regarding the genetic makeup and the risk of passing the disorder to future generations.
Conducted by DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test is priced at 4400 AED. DNA Labs UAE employs cutting-edge technology and adheres to stringent quality control measures to ensure accurate and reliable test results, making it a trusted choice for genetic testing in the region.
The CERS1 Gene Progressive Myoclonus Epilepsy Type 8 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CERS1 gene, which are implicated in the development of Progressive Myoclonus Epilepsy Type 8 (PME-8). PME-8 is a rare, inherited neurological disorder characterized by a combination of myoclonic seizures (sudden, involuntary muscle jerks) and progressive neurological decline. This condition is part of a group of diseases known as the progressive myoclonus epilepsies, which vary in their cause and genetic background.
The genetic test involves analyzing the patient's DNA to detect specific mutations in the CERS1 gene that are known to cause PME-8. Early and accurate diagnosis through genetic testing can be crucial for the management of the condition, allowing for tailored treatment plans and genetic counseling for affected families.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its expertise in genetic diagnostics and personalized medicine. The cost reflects the complex nature of the genetic analysis and the significant insight it provides into managing a rare and challenging condition like PME-8.
The TANC1 gene psychomotor retardation genetic test is a specialized diagnostic tool designed to identify mutations in the TANC1 gene, which are linked to certain forms of psychomotor retardation. Psychomotor retardation is a condition characterized by a significant slowing-down of thought and a reduction of physical movements, often resulting in delayed developmental milestones. The TANC1 gene plays a critical role in brain development and function, and mutations in this gene can lead to various neurological and developmental disorders.
This genetic test is crucial for early diagnosis and intervention, offering insights that can guide therapeutic and support strategies to improve the quality of life for affected individuals and their families. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy and reliability, employing advanced genomic technologies to detect the presence of mutations in the TANC1 gene.
The cost of the TANC1 gene psychomotor retardation genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis and detailed reporting necessary to understand the implications of the test results. By identifying the genetic underpinnings of psychomotor retardation, this test paves the way for personalized treatment plans and offers hope for better management of the condition.
The HARS2 Gene Perrault Syndrome Type 2 Genetic Test is a specific diagnostic tool available at DNA Labs UAE, aimed at identifying mutations in the HARS2 gene, which are linked to Perrault Syndrome Type 2. Perrault Syndrome is a rare genetic disorder characterized by sensorineural hearing loss in males and females, coupled with ovarian dysfunction in females, leading to premature ovarian failure. This condition can also present additional neurological symptoms in some cases.
The test involves analyzing the patient's DNA to detect mutations in the HARS2 gene, which plays a crucial role in mitochondrial protein synthesis. Mutations in this gene disrupt normal cellular functions, leading to the manifestations of Perrault Syndrome. Early and accurate diagnosis through this genetic test can aid in better management of the condition, although there is currently no cure. It provides crucial information for affected individuals and their families regarding the nature of the disorder, potential treatments, and implications for family planning.
The cost of the HARS2 Gene Perrault Syndrome Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the expertise required to interpret the results, and the comprehensive care associated with genetic counseling that may follow the diagnosis. DNA Labs UAE is equipped with advanced technology and staffed by professionals skilled in genetic diagnostics, ensuring reliable and accurate test results.
The LARS2 gene Perrault Syndrome Type 4 genetic test is a specialized diagnostic tool used to detect mutations in the LARS2 gene, which are linked to Perrault Syndrome Type 4. Perrault Syndrome is a rare genetic disorder characterized by sensorineural hearing loss in both males and females and premature ovarian failure in females. The LARS2 gene plays a crucial role in mitochondrial function, and mutations in this gene can disrupt normal cellular activities, leading to the symptoms observed in affected individuals.
This genetic test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any mutations in the LARS2 gene. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it provides.
Opting for this test can be particularly important for families with a history of Perrault Syndrome or individuals showing symptoms related to the disorder. Early diagnosis through genetic testing can aid in better understanding the condition, facilitating informed decisions about management and treatment options. It also helps in genetic counseling for affected families, providing them with crucial information regarding the inheritance patterns and risks of passing the condition to future generations.
The TWNK Gene Perrault Syndrome Type 5 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TWNK gene, which are associated with Perrault Syndrome Type 5. Perrault Syndrome is a rare genetic disorder characterized by sensorineural hearing loss in both males and females and premature ovarian failure in females. The test plays a crucial role in the early detection and management of this condition, enabling healthcare providers to offer tailored treatments and interventions.
At DNA Labs UAE, the test is offered at a cost of 4400 AED. The process involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for any genetic anomalies in the TWNK gene. Results from this test can provide valuable insights into the patient's condition, guiding clinical decisions and offering families an understanding of the genetic underpinnings of their health concerns. This test is a vital resource for individuals with a family history of Perrault Syndrome or related symptoms, offering a path towards a more informed and proactive approach to health and wellness.
The PGK1 gene, responsible for encoding the enzyme phosphoglycerate kinase 1, plays a crucial role in the glycolytic pathway, converting 1,3-bisphosphoglycerate to 3-phosphoglycerate and generating ATP in the process. Deficiencies in this enzyme can lead to a range of clinical manifestations, including hemolytic anemia, myopathy, and neurological disorders, making the accurate diagnosis of PGK1 gene deficiency critical for proper management and treatment.
In response to the need for precise diagnostic tools, DNA Labs UAE offers a genetic test specifically designed to identify mutations in the PGK1 gene. This test is a comprehensive examination aimed at detecting genetic variations that could lead to phosphoglycerate kinase 1 deficiency, thereby providing essential information for clinicians to devise appropriate treatment strategies.
The cost of the PGK1 Gene Phosphoglycerate Kinase 1 Deficiency Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the detailed analysis and the expertise required to interpret the results accurately, ensuring that patients receive the most relevant information regarding their genetic condition. By opting for this test, individuals suspected of having PGK1 deficiency can take a significant step towards understanding their condition and exploring potential treatment options.
The PSEN1 Gene Pick Disease Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the PSEN1 gene, which are associated with Pick's disease, a type of frontotemporal dementia. This condition is characterized by changes in personality, behavior, and language due to brain cell damage. The PSEN1 gene plays a crucial role in the production of the presenilin 1 protein, involved in the processing of amyloid precursor protein, a substance that, when improperly cleaved, can lead to the accumulation of amyloid plaques, a hallmark of several forms of dementia, including Pick's disease.
The test is conducted through a blood sample, where DNA is extracted and analyzed for specific mutations in the PSEN1 gene. This genetic testing is crucial for individuals with a family history of Pick's disease or early-onset dementia, as it can provide vital information for the management and understanding of the condition. The cost of the PSEN1 Gene Pick Disease Genetic Test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise required to perform this detailed genetic analysis. Early detection through this test can be instrumental in planning the appropriate care and support for affected individuals and their families.
The TREM2 gene plays a critical role in the immune system, particularly in the brain's immune response. Mutations in this gene are linked to a rare condition known as Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease. This genetic disorder is characterized by a combination of bone cysts leading to fractures and progressive neurological deterioration due to leukoencephalopathy, which affects the white matter of the brain.
To diagnose and understand the genetic basis of PLOSL, a genetic test targeting the TREM2 gene can be conducted. This test is crucial for confirming the diagnosis, understanding the risk of transmission to offspring, and guiding management and treatment decisions.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED, making it accessible for those who require this critical diagnostic tool. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for mutations in the TREM2 gene. Results from this test can provide essential insights into the condition, facilitating targeted treatment and management strategies for affected individuals and their families.
The TYROBP gene plays a crucial role in the development of Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease. This rare, genetic disorder is characterized by bone cysts and progressive neurological deterioration. The genetic test for identifying mutations in the TYROBP gene is crucial for diagnosing PLOSL, enabling early intervention and management of the condition.
DNA Labs UAE offers this specialized genetic test to detect mutations in the TYROBP gene associated with PLOSL. The test is performed using a sample of the patient's blood or saliva, employing advanced genetic sequencing techniques to accurately identify mutations. The cost of the test is 4400 AED, a valuable investment for individuals with a family history of the disorder or presenting symptoms of PLOSL, as it provides essential diagnostic information that can guide treatment and management decisions.
